JP Morgan analyst Jeffrey Zekauskas downgrades Dow (NYSE:DOW) from Overweight to Neutral.
Aurinia Presents Breadth Of Data At ASN 2023 Demonstrating Clinical Importance Of LUPKYNIS For Managing Lupus Nephritis
Patients treated with LUPKYNISⓇ in a repeat kidney biopsy sub-study achieved improvement in histologic activity with stable chronicity scores and no evidence of chronic injury.A propensity analysis of AURORA 1 suggested